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In this study, we investigated the dynamics of the molecular interactions of tetraspanin CD81 in T lymphocytes, and we show
that CD81 controls the organization of the immune synapse (IS) and T cell activation. Using quantitative microscopy, including
fluorescence recovery after photobleaching (FRAP), phasor fluorescence lifetime imaging microscopy-Föster resonance energy
transfer (phasorFLIM-FRET), and total internal reflection fluorescence microscopy (TIRFM), we demonstrate that CD81 inter-
acts with ICAM-1 and CD3 during conjugation between T cells and antigen-presenting cells (APCs). CD81 and ICAM-1 exhibit
distinct mobilities in central and peripheral areas of early and late T cell-APC contacts. Moreover, CD81–ICAM-1 and CD81-
CD3 dynamic interactions increase over the time course of IS formation, as these molecules redistribute throughout the contact
area. Therefore, CD81 associations unexpectedly define novel sequential steps of IS maturation. Our results indicate that CD81
controls the temporal progression of the IS and the permanence of CD3 in the membrane contact area, contributing to sustained
T cell receptor (TCR)-CD3-mediated signaling. Accordingly, we find that CD81 is required for proper T cell activation, regulat-
ing CD3, ZAP-70, LAT, and extracellular signal-regulated kinase (ERK) phosphorylation; CD69 surface expression; and inter-
leukin-2 (IL-2) secretion. Our data demonstrate the important role of CD81 in the molecular organization and dynamics of the
IS architecture that sets the signaling threshold in T cell activation.
The interaction between T lymphocytes and antigen-presentingcells (APCs) is essential for the initiation of the immune re-
sponse. The dynamic structure formed at cell-to-cell contacts be-
tween T cells and APCs, called the immune synapse (IS), is char-
acterized by controlled recruitment of membrane receptors to
specific subcellular sites (1). Upon activation by an APC, T cell
molecules involved in the IS redistribute in highly organized
structures at the T cell-APC contact (2). The T cell receptor (TCR)
and associated molecules concatenate into the central area (cen-
tral supramolecular activation cluster [cSMAC]), whereas adhe-
sion receptors rearrange in a surrounding external ring called the
peripheral supramolecular activation cluster (pSMAC) (3). Dur-
ing IS formation, preclustered TCR “protein islands” converge
into larger aggregates that translocate toward the cSMAC (4, 5),
from where they are internalized and degraded (6). The balance
between the generation and degradation of TCR microclusters is
critical for sustained T cell activation (5, 7) and is modulated by
ligand mobility (8). However, the mechanisms regulating protein
receptor movement and the basis for IS molecular segregation are
still poorly understood.
A plethora of molecules are translocated to the IS during T cell
activation (9). These include the tetraspanins CD81 (10) and
CD82 (11), which are known to associate with several IS compo-
nents such as major histocompatibility complex class II (MHCII)
molecules, CD4, and LFA-1 (12–15). However, the specific role of
tetraspanins in the IS remains unknown. Tetraspanins are ubiq-
uitous proteins that modulate the function of their associated
partners and play important roles in a wide variety of physiologi-
cal and pathological processes, including immunity and inflam-
mation (16). They interact with each other and with other recep-
tors, cytoskeletal components, and signaling molecules, acting as
organizers of molecular macrocomplexes called tetraspanin-en-
riched microdomains (TEMs) (17). The existence of TEMs has
been demonstrated by biochemical approaches (16, 18) and by
single-molecule fluorescence techniques in living cells (19, 20). In
the immune system, it has been shown that CD81 provides a co-
stimulatory signal in T cells, associates with CD19, and facilitates
antigen presentation by associating with MHCII molecules in
APCs (21). Mice deficient for CD81 have hyperactive B cells (22),
delayed humoral immune responses, impaired T helper type 2
responses, and hyperproliferative T cells (21). In T cells, TEM
insertion has been demonstrated for CD4 and CD8 coreceptors
(13, 23) and for VLA-4 and LFA-1 integrins (15, 24). ICAM-1, the
adhesion receptor ligand for the LFA-1 integrin, is also a TEM
component, mediating intercellular adhesion (25). Although
ICAM-1 has been thoroughly studied on APCs, ICAM-1 and
LFA-1 are present on both APCs and T lymphocytes. ICAM-1
expression on T cells (26–28) and LFA-1 expression on APCs (29,
30) can also play a role in T cell-APC contact (31–36). Moreover,
CD81 cross-linking stimulates LFA-1–ICAM-1-mediated thymo-
cyte aggregation (37) and promotes T cell-B cell interactions by
activating LFA-1 integrin (38). Thus, tetraspanins might have an
important role in IS organization.
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Here, we investigated the role of the tetraspanin CD81 as an IS
organizer in live T cell-B cell conjugates. Using state-of-the-art
microscopy approaches, we show that CD81 is a critical regulator
of the IS architecture on the T cell side of the T cell-APC contact.
Our data also reveal that CD81 controls the staging of IS matura-
tion through its interaction with CD3 and ICAM-1. This is due, at
least in part, to its role in controlling CD3 clustering and perma-
nence at the IS. Thus, CD81 is a critical regulator of CD3 cluster-
ing, sustained CD3 signaling, and T cell activation.
MATERIALS AND METHODS
Antibodies, reagents, peptides, and recombinant DNA constructs.
Poly-L-lysine (PLL), influenza virus hemagglutinin (HA) peptide, and un-
conjugated and fluorescein isothiocyanate (FITC)-conjugated anti--tu-
bulin were obtained from Sigma. Staphylococcus enterotoxin E (SEE) was
obtained from Toxin Technology. Alexa Fluor 488 and 647, streptavidin-
Alexa Fluor 488, rhodamine X, phalloidin-Alexa Fluor 488 and -Alexa
Fluor 647, anti--tubulin–Alexa Fluor 647, and the cell tracker CMAC
(7-amino-4-chloromethylcoumarin) were obtained from Invitrogen. The
antibodies (Abs) T3b (anti-CD3), TP1/40 (anti-L integrin), TS1/18 (an-
ti-2 integrin), HU5/3 (anti-ICAM-1), TP1/55 (anti-CD69), VJ1/20 (an-
ti-CD9), LIA1/1 (anti-CD151),HP2/6 (anti-CD4), andT200 (anti-CD45)
were produced in our laboratory. CD81 monoclonal Ab (MAb) 5A6,
CD3 polyclonal Ab (pAb) 448, CD82 MAb TS82b, and MEM53 MAb
CD53 were kindly provided by S. Levy (Stanford, CA, USA), B. Alarcón
(CBM, Spain), E. Rubinstein (Institut André Lwoff, Villejuif, France), and
V. Horejsí (Czechoslovak Academy of Sciences, Prague, Czech Republic),
respectively. Antibodies against phospho-phospholipase C- (phospho-
PLC-) (Y783), PLC-, phospho-ZAP-70 (Y493), and phospho-Erk1/2
(T202/Y204) were obtained from Cell Signaling. ZAP-70 Ab, LAT Ab,
phospho-CD3 (Y83), and phospho-LAT (Y132) were obtained fromAb-
cam. Erk1/2 Abwas obtained fromMillipore, and CD69-allophycocyanin
was obtained from BD Biosciences.
Tetramethylrhodamine (TAMRA)N-terminally labeled peptides with
the sequence RRRRRRRCCGIRNSSVY (CD81) or RRRRRRRYSVNICR
GCSS (scrambled) were purchased from LifeTein (South Plainfield, NJ,
USA). Glutathione S-transferase (GST) alone and GST-LEL-CD81 pep-
tides were prepared as described previously (25).
For the CD81-mCherry construct (with the mCherry tag at the C-ter-
minal domain), a CD81 PCR product was subcloned into pEGFP-C1
(Invitrogen), in which the enhanced green fluorescent protein (EGFP)
sequence was replaced by the monomeric Cherry (mCherry) sequence.
This construct was kindly provided by E. Rubinstein. The constructs
pEGFP-N1-CD3 (39), provided by B. Alarcón; CD9-mEGFP; and
ICAM-1–mEGFP (19) were previously described. ICAM-3 tagged with
monomeric EGFP (mEGFP) was obtained from ICAM-3–EGFP (40) by
using a QuikChange Multi site-directed mutagenesis kit from Stratagene
(La Jolla, CA, USA).
Cells and cell culture.V8 Jurkat T cell clones (J77) and the lympho-
blastoid Raji and Hom2 (HLA-DR1 Epstein-Barr virus [EBV]-trans-
formed) cell lines were cultured in RPMI 1640 medium (Sigma) supple-
mented with 10% fetal calf serum (FCS; Invitrogen), and HEK293T cells
were cultured in Dulbecco’s modified Eagle’s medium (DMEM) (Sigma)
supplemented with 10% FCS. HA-specific V3 Jurkat T cells (CH7C17)
were supplemented with 400 g/ml hygromycin B (Invitrogen) and 4
g/ml puromycin (Sigma). Stable cell populations overexpressing CD81-
mCherry or ICAM-1–mEGFP were generated by transfection and selec-
tion with 1 mg/ml G418 (Invitrogen).
Peripheral blood lymphocytes from healthy donors were isolated by
Ficoll-Hypaque gradient centrifugation and cultured for 2 days in RPMI
1640 medium supplemented with 10% fetal bovine serum (FBS) (Cam-
brex Bioscience) and SEE (0.1 g/ml). Isolated T lymphoblasts were then
maintained in culture for 5 days in the presence of interleukin-2 (IL-2) (50
U/ml).
Cell transfection and silencing. J77 cells (2 107) were washed twice
with Hanks’ balanced salt solution (HBSS) (Lonza) and transiently trans-
fected by electroporation with plasmids (20 g) or cotransfected with
plasmids (10 g) and small interfering RNA (siRNA) (1 M) in
OptiMEMmedium (Gibco, Invitrogen) at 240 V and 32 ms (Gene Pulser
II; Bio-Rad). Control siRNA and siRNA for CD81 (siCD81) (CACGTCG
CCTTCAACTGTA) were purchased from Eurogentec.
For lentiviral silencing of endogenous CD81, short hairpin RNA
(shRNA) lentiviruses were produced by cotransfection of HEK293T cells
(Lipofectamine 2000; Invitrogen) with pLVX-shRNA2 (with Zsgreen flu-
orescence; Clontech), encoding the shRNA sequence (the same sequence
as siCD81), or with an empty plasmid as a control, together with plasmids
pCMV-R8.91 and pMD2.G-VSV-G. Supernatants were collected after
48 to 72 h andfiltered (0.45m;Millipore). J77 orCH7C17 cells were spin
infected for 2 h at 1,200 g and incubated for 4 h at 37°C. Two rounds of
transduction were performed at 24-h intervals, and experiments were
carried out after a further 48 h. Results were confirmedwith two indepen-
dent sequences of shRNA to control for off-target effects. siRNA or
shRNA knockdownwas tested by flow cytometry at 48 h posttransfection.
Conjugate formation. B cells (Raji or Hom2) were loaded with the
CMAC tracker and loaded with SEE (0.5 to 1 g/ml) or HA peptide (100
to 200 g/ml), as appropriate (41). J77 or CH7C17 T cells were mixed
with Raji or Hom2 B cells (1:1), centrifuged at low speed to favor conju-
gate formation, and incubated at 37°C for the indicated periods of time.
CH7C17 T cells were incubated for 3 h at 37°C with 10Mpermeable
CD81 or scramble peptides or alternatively with 150 g/ml of GST alone
or the GST-LEL-CD81 fusion protein. Pretreated T cells were then con-
jugated with Hom2/HA B cells for 16 h at 37°C, stained with antibodies
against CD69, and analyzed by flow cytometry.
Flow cytometry.Cells were cocultured in 96-well plates at 37°C for the
indicated periods. After staining of cells with specific antibodies, datawere
acquired with a FACSCantoII flow cytometer (BD) and then analyzed
with BD FACSDIVA (BD) or FlowJo software (FlowJo Inc.). B cells were
distinguished by CMAC staining, and in shRNA experiments, T cells were
distinguished by Zsgreen fluorescence.
To measure F-actin content, J77 cells were stimulated for different
times with 10 g/ml purified anti-CD3 (T3b), fixed in 2% paraformalde-
hyde (PFA), permeabilized in 0.5% Triton X-100 in phosphate-buffered
saline (PBS), and labeledwith phalloidin. All experimentswere performed
in triplicates.
IL-2 production. shRNA-transduced J77 T cells were conjugated with
SEE-loaded Raji B cells. For measurement of IL-2 secretion, supernatants
were harvested after 16 h, and IL-2 content was measured by using the
IL-2 ELI-pair kit (Diaclone).
Immunoblotting. shRNA-transduced J77 T cells were conjugated
with SEE-loaded Raji B cells (10:1) for the indicated times and lysed with
1% Triton X-100 in PBS containing Complete protease and PhoSTOP
phosphatase inhibitors (Roche). Proteins were separated by SDS-PAGE,
and proteins were revealed with the Fujifilm LAS-3000 imaging system
after membrane incubation with specific antibodies and peroxidase-con-
jugated secondary antibodies. Band intensities were quantified by using
Metamorph software (MolecularDevices), and resultswere normalized to
the total protein expression level.
Fluorescence confocal microscopy. For immunofluorescence, T
cell-B cell conjugates formed by incubation for different times at 37°C
were allowed to adhere onto PLL-coated coverslips (40g/ml) for 15min
at 37°C and fixed in 4% PFA (Electron Microscopy Sciences). Samples
were fixed, stained with appropriate primary antibodies followed by spe-
cies-matching secondary antibodies or streptavidin (when primary anti-
bodies were biotinylated) coupled to Alexa Fluor fluorochromes (Invit-
rogen), andmounted in Prolong antifademedium (Invitrogen). To detect
intracellular proteins, cells were first permeabilized with PBS–0.5% Tri-
ton X-100 for 5 min.
For live-cell imaging,microscopes were fully covered by an acrylic box
to allow analysis at 37°C in 5%CO2. For time-lapse fluorescence imaging,
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cells were resuspended in HBSS (Lonza)–2% FCS—20 mM HEPES
(Lonza), plated onto PLL-coated 35-mm dishes (MatTek), and main-
tained at 37°C in 5% CO2.
Confocal images were obtained with a Leica TCS-SP5 confocal scan-
ning laser unit attached to an inverted epifluorescence DMI6000Bmicro-
scope fitted with an HCX PL APO lambda blue 63/1.4-numerical-aper-
ture (NA) oil immersion objective, using Las-AF acquisition software
(LeicaMicrosystems), or alternatively with a Zeiss LSM700 confocal scan-
ning laser unit attached to an inverted epifluorescence microscope (Ob-
server.Z1) fitted with a Plan APO Chromat 63/1.4-NA oil immersion
objective, using ZEN 2009 acquisition software (Carl Zeiss Microscopy
GmbH). Images were analyzed with Leica LAS-AF, Metamorph, or Im-
ageJ software (NIH).
Protein relocalization to the IS was quantified with the Synapsemea-
sure plug-in in ImageJ (42). Briefly, the quantification takes into account
the fluorescence intensity signals measured in selected regions with simi-
lar areas at the T cell-APC contact zone (IS), the APC membrane not in
contact with the T cell (B), the T cell membrane not in contact with the
APC (T), and the background (Bg). Bg signal was subtracted from all
other measurements, and signal accumulation at the IS relative to the rest
of the T cell surface was then analyzed according to the formula (IS 
B)/T. In the charts, each dot corresponds to a T cell-B cell conjugate.
Measurements of Pearson’s coefficient for the colocalization of CD3-
mEGFP and CD81-mCherry or ICAM-1–mEGFP and CD81-mCherry
were performed with Imaris (Bitplane). We analyzed the three-dimen-
sional (3D) IS contact area from time-lapse stack confocal microscopy
videos. For each cell-cell conjugate, measurement of GFP-Cherry colocal-
ization was performed considering for all confocal stacks only the 1 m
closest to the Raji B cell membrane.
Fluorescence recovery after photobleaching (FRAP). J77/CD81-
mCherry or J77/ICAM-1–mEGFP cells were incubatedwith Raji/SEE cells
for 2 min and plated for 5 min onto PLL-coated coverslips. Live-cell mi-
croscopy was performed at 37°C in 5% CO2 with a Nikon A1-R multiline
confocal scanning unit coupled to an Eclipse Ti microscope fitted with a
PLAPO60/1.4-NAoil immersion objective, the 488-nmAr laser line for
ICAM-1–mEGFP, or the 561-nm diode laser line for CD81-mCherry.
Bleaching was conducted onmembrane areas of the central or pSMAC of
the early and late IS and on comparable areas of the plasma membrane of
nonconjugated T cells. Laser power for bleaching was maximal but was
reduced to 10% for imaging. At the optimal focal plane, the acquisition
protocol was as follows: 10 prebleach images, 1 s of iterative bleach pulse,
60 images at 1-s intervals, 30 images every 10 s, and 3 images every 30 s
(256 by 256). Fluorescence recovery in the bleached region (8.4 m2 for
ICAM-1–mEGFP and 8.94m2 for CD81-mCherry) wasmeasured as the
average signal intensity. All recovery curves were generated as described
previously (19). The averaged recoveries were fitted by using a simple
Brownian diffusionmodel with GraphPad Prism. Statistical analyses were
performed on the raw data for each protein and each condition. The
immobile fractions and half-recovery times were determined from the
fitted curves.
Hetero-Föster resonance energy transfer (FRET) by donor phasor
fluorescence lifetime imaging microscopy (phasorFLIM) in intact liv-
ing cells. J77 T cells were transiently cotransfected with proteins fused to
monomeric EGFP (ICAM-1–mEGFP, CD3-mEGFP, CD9-mEGFP, or
ICAM-3–mEGFP) and CD81-mCherry by electroporation. After 24 h,
cells expressing intermediate levels (mean fluorescence intensity at fluo-
rescence detector FL-2 of 102 to 104) of mEGFP-tagged protein and high
levels (mean fluorescence intensity at FL-1 of 103 to 105) of CD81-
mCherry were sorted on a FACSAriaII flow cytometer (BD) and cultured
for at least 2 h. Cells were then incubated with Raji/SEE cells for 2min and
plated for 10 min onto PLL-coated 35-mm dishes at 37°C (MatTek) be-
fore analysis. CMAC was used at a 100-times-lower concentration than
that used for other experiments to avoid interference with EGFP fluores-
cence under multiphoton excitation.
FLIM images were collected at 37°C in 5% CO2 in raster scanning
mode using a 2-channel Alba spectrometer (ISS Inc.) combined with a
digital frequency domain (DFD) fast-FLIM card (ISS Inc.) and equipped
with H7422 fast photomultipliers (Hamamatsu Photonics). The ALBA
module was coupled to an inverted Nikon Ti-E microscope (Nikon
Corp.) equipped with a Nikon MRD07600 CFI 60/1.2-NA WI Plan
Apochromatic objective, an epifluorescence lamp, a bright field, a top-
stage incubator, and a heating chamber (Okolab SRL). Excitation at 830
nm was provided by a femtosecond-pulsed mode-locked tunable MaiTai
DeepSee laser (Newport Corp.). Emission signals were collected after
blocking with FF01-680/SP and BP530/43 filters (Semrock Inc., Idex Cor-
poration). The laser power at the objective was 10mW.A series of 20 to 50
consecutive 256-by-256-pixel images at 64s/pixel were averaged. Phasor
analysis was carried out by using SimFCS (Globals Unlimited, LFD). We
analyzed the dispersion of the donor fluorophore alone in the phasor plot
to determine the size of the cursor and considered only the pixels identi-
fied outside the distribution of the donor-only cells (43). For each
mEGFP-mCherry pair of proteins, the highest FRET efficiency was se-
lected (27% for CD81-CD9, 23% for CD81–ICAM-1, and 22% for CD81-
CD3), always maintaining the same cursor size, and the number of pixels
inside the cursor was quantified.
TIRFM. J77T cells were cotransfectedwithCD3-mEGFP and control
orCD81 siRNA, sorted on a FACSAriaII flow cytometer, cultured for 24 h,
and plated onto 35-mm dishes (MatTek) coated with 10 g/ml purified
anti-CD3 (T3b). Images were acquired for 10 min at 0.35-s intervals on a
LeicaAM total internal reflection fluorescencemicroscopy (TIRFM)mul-
ticolor unit mounted on a Leica DMI6000B microscope fitted with a
100/1.46-NA oil immersion objective, using a1.6 magnification and
	90-nm depth penetration (analysis of microclusters at the cell mem-
brane). Images were analyzed with Imaris (Bitplane). For the analysis of
CD3 cluster movement, background was subtracted by using the local
contrast threshold. The minimum cluster diameter was then estimated to
be 0.4 m, and a Brownian motion algorithm was applied, considering 2
m as the maximum distance of cluster displacement and no gaps be-
tween frames. For the analysis of cSMAC areas, absolute intensity was
used for thresholding.
Statistical analysis. All statistical analyses were performed with
GraphPad Prism (GraphPad Software Inc.). P values were calculated by
using two-tailed Student’s t test or, when specified, one-way analysis of
variance (ANOVA)with Bonferroni’s or Tukey’s (for analysis of variance)
post hocmultiple-comparison test. Statistical significance was assigned at
P values of
0.05 (indicated by  in the figures),
0.01 (indicated by ),
and
0.001 (indicated by ).
RESULTS
CD81 dynamics during IS progression. To test the potential role
of CD81 in membrane protein reorganization during IS forma-
tion, we first assessed CD81 redistribution during T cell-B cell
conjugation, comparing it to the redistribution of markers of the
cSMAC (CD3) and pSMAC (ICAM-1). Primary human T lym-
phoblasts were conjugated with Raji B cells labeled with CMAC
cell tracker and loaded with superantigen E (Raji/SEE cells) for
different times, plated onto poly-L-lysine-coated coverslips for 10
min, fixed, and stained with antibodies against CD81 and CD3 or
CD81 and ICAM-1 (Fig. 1). CD81 was enriched at the IS, colocal-
izing with CD3 at the cSMAC in 10-min conjugates, while
ICAM-1 was enriched at the pSMAC. In later conjugates, after 30
min of cell-cell contact, CD81 and ICAM-1 were equally distrib-
uted throughout the IS, while CD3 remained accumulated at the
cSMAC (Fig. 1).
To further investigate the dynamics of CD81 redistribution at
the IS during T cell-B cell conjugation, J77 T cells cotransfected
with CD81-mCherry and CD3-mEGFP were conjugated with
Raji/SEE cells, and conjugates were analyzed by time-lapse confo-
cal microscopy (Fig. 2). CD81 relocalized to the IS within the first
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minutes of conjugation, colocalizing with CD3 at the cSMAC, and
remained in this location for up to 20 min (Fig. 2A). Quantifica-
tion of CD81-mCherry and CD3-mEGFP Pearson’s coefficients
at the 3D IS contact area showed high levels of colocalization at all
times analyzed (Fig. 2A, right). To compare the dynamics of CD81
redistribution at the IS with a pSMAC marker, we used the adhe-
sion molecule ICAM-1, since fluorescently tagged integrins were
not stable and did not show proper subcellular distribution (data
not shown), precluding its use in studies based on fluorescence
microscopy. Although ICAM-1 is typically seen as a pSMAC com-
ponent at the APC side and is highly expressed on APCs, it is also
endogenously expressed by T cells (see Fig. S1A in the supplemen-
tal material). In addition, Raji and Hom2 B cells, used as APCs,
endogenously expressed the integrin LFA-1 (L2) (see Fig. S1B in
the supplemental material). J77 T cells were cotransfected with
CD81-mCherry and ICAM-1–mEGFP and conjugated with Raji/
SEE cells (Fig. 2B). During the initial phase of the early IS, CD81
but not ICAM-1 was enriched at the central area (Fig. 2B). Quan-
tification of ICAM-1–mEGFP and CD81-mCherry Pearson’s co-
efficients at the contact area in time-lapse videos indicated that
CD81–ICAM-1 colocalizationwas enhancedwith the time of con-
jugation, reaching a peak by 10 min of cell-cell contact (Fig. 2B,
right). Indeed, by that time, ICAM-1 started to relocalize through-
out the IS. At later times, after	20 min, CD81 was also redistrib-
uted from the cSMAC so that ICAM-1 and CD81 proteins colo-
calized at the entire cell-cell contact (Fig. 2B). Likewise, CD3
exhibited a similar redistribution pattern after	50min (Fig. 2C).
We could therefore define an early stage in the IS in which CD81
and CD3 colocalized at the cSMAC while ICAM-1 was located at
the pSMAC and a late IS in which all three receptors redistributed
along the entire IS cell-cell contact. These data suggest that CD81
might be important in the initiation of antigen-triggered CD3
clustering.
We next investigated the mobility of CD81 at the IS by using
FRAP (fluorescence recovery after photobleaching). J77/CD81-
mCherry T cells were conjugated with Raji/SEE cells, and the
cSMAC or pSMACmembrane areas of T cells were bleached dur-
ing early or late IS formation (Fig. 3A). Fluorescence recovery
under each condition was measured, and the immobile fractions
and half-recovery times of the mobile fractions were obtained
from the fitted curves. The apparent diffusion coefficients in con-
trol nonconjugated T cells and in different areas and phases of the
IS were also calculated (Table 1). We found that a greater propor-
tion ofCD81moleculeswere immobile at the early IS cSMAC than
at the cell membrane of control nonconjugated T cells, whereas
the immobile fraction at the pSMACwas similar to that in control
cells, indicating that CD81 is confined mostly to the early IS
cSMAC (Fig. 3B andD). In both areas of the early IS, the diffusion
dynamics of mobile CD81molecules remained similar to those in
control cells (Fig. 3B and E and Table 1), as indicated by the half-
recovery times and the calculated apparent diffusion coefficients.
In the late IS, the CD81 immobile fraction increased in both the
cSMAC and pSMAC with respect to nonconjugated cells (Fig. 3C
and D). Moreover, the mobile CD81 molecules showed a slower
mobility than in control cells (Fig. 3C and E and Table 1), suggest-
ing a general decrease in diffusion consistent with more stable
protein-protein interactions in both areas.
We compared the observed CD81 dynamics with that of
ICAM-1, which is included in TEMs (25). J77/ICAM-1–mEGFPT
cells conjugated with Raji/SEE cells were bleached at the cSMAC
or pSMAC during early or late IS formation (Fig. 3F). FRAP anal-
ysis revealed a higher ICAM-1 immobile fraction in the early IS
pSMAC than in nonconjugated T cell membranes (Fig. 3G and I),
and mobile molecules entering this area moved more slowly (Fig.
3G and J and Table 1). ICAM-1 dynamics in the early IS cSMAC
was similar to that in control cells (Fig. 3G, I, and J and Table 1),
indicating that ICAM-1 is confinedmostly to the early pSMAC. In
the late IS, both areas showed reduced diffusion dynamics in com-
parison to those in nonconjugated cells, but more ICAM-1 mole-
cules were immobile in central than in peripheral areas, suggesting
stronger interactions (Fig. 3H to J and Table 1).
CD81molecular interactionswithinTEMsdefine ISmatura-
tion stages. We then assessed in living cells the dynamics of pro-
tein-protein interactions at the contact area during IS maturation
by using phasor fluorescence lifetime imaging microscopy
(phasorFLIM)-Föster resonance energy transfer (FRET) (43, 44).
J77 T cells were cotransfected withmonomeric EGFP-tagged pro-
teins (43, 45) as the donor (CD9-mEGFP, ICAM-1–mEGFP, or
FIG 1 CD81, CD3, and ICAM-1 enrichment at the IS. Primary human T lymphoblasts were conjugated with CMAC-labeled SEE-loaded Raji B cells (blue)
(asterisks) for 10 or 30 min. Cells were then plated onto PLL-coated coverslips, fixed, and stained with antibodies against CD81 (red) and CD3 or ICAM-1
(green). A single confocal plane is shown. Bars, 10 m.
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CD3-mEGFP) and CD81-mCherry as the acceptor. Cells were
conjugated with Raji/SEE cells and imaged. The fluorescence life-
time of donor mEGFP-fused constructs in cotransfected cells was
compared with that in control cells expressing only mEGFP-
tagged donor molecules. Donor-acceptor interactions were mea-
sured as the localization and percentage of the number of pixels
detected at the highest FRET efficiency (FRETeff) for each pair,
which can vary as a function of the distance between the two
fluorophores and/or the affinity between the proteins. Phasor-
FLIM-FRET analysis of ICAM-3–mEGFP and CD81-mCherry
pairs, used as the negative control, showed an average FRETeff
value similar to that of the donor fluorophore alone, and the
percentage of pixels with FRETeff above the uncertainty of the
measurement was negligible (see Fig. S2A in the supplemental
material). PhasorFLIM-FRET analysis revealed a CD81-CD9 het-
erophilic interaction in nonconjugated cells (Fig. 4A; see also Fig.
S2B in the supplemental material), in agreement with previous
biochemical data (46, 47). Tetraspanin CD9 was also enriched at
the IS, displaying different IS relocalization kinetics in compari-
son to those of CD81 (see Fig. S3 in the supplemental material).
Interestingly, theCD81-CD9 interactionwas enhanced by cell-cell
conjugation (Fig. 4A), suggesting that conjugation prompted
stronger TEM interactions. In nonspecific contacts, with no CD9
clustering in the contact area, the extent of the CD9-CD81 inter-
actionwas similar to that in nonconjugated cells. The extent of the
association increased progressively during IS formation, from ini-
tial cognate contacts to the early cSMAC and throughout the con-
tact in the late IS (Fig. 4A).
FIG2 CD81, CD3, and ICAM-1 relocalization depends on ISmaturation. J77 cells transfectedwithCD81-mCherry andCD3-mEGFP (A), CD81-mCherry and
ICAM-1–mEGFP (B), or CD3-mEGFP (C) were conjugated with Raji/SEE cells (blue) (asterisks). Cells were monitored by time-lapse confocal microscopy at
	1.5-min intervals. A single confocal plane is shown. Bars, 10 m. In panels A and B, right graphs represent measurements of Pearson’s coefficient for
mEGFP-mCherry colocalization at the 3D IS contact areas over the conjugation period.Measurementswere performed on time-lapse stack confocal images from
the CD3-mEGFP and CD81-mCherry (A) or ICAM-1–mEGFP and CD81-mCherry (B) IS, as in the examples depicted in the left panels. Data are means 
standard errors of the means of 16 (A) and 11 (B) cells (n 2 independent experiments each).
Rocha-Perugini et al.
3648 mcb.asm.org Molecular and Cellular Biology
FIG 3 CD81 and ICAM-1 dynamics at the IS. J77/CD81-mCherry (A to E) or J77/ICAM-1–mEGFP (F to J) cells were conjugated with Raji/SEE cells (asterisks).
FRAPwas conducted on the cSMACor pSMACof early and late ISs and on nonconjugated T cells. Data were analyzed by one-way ANOVAwith Tukey’s post hoc
multiple-comparison test. (A) Example prebleach, bleach, and final postbleach images depicted in pseudocolor intensity-coding format (maximum intensity in
white): white circles, bleached areas; green circles, membrane areas distant from the bleached areas, used as an internal control; red circles, background. (B)
Mean-fitted fluorescence recovery curves standard errors of themeans for nonconjugated cells (n 12), the cSMAC (n 11), and the pSMAC (n 10) of the
early IS. (C) Mean-fitted fluorescence recovery standard error of the mean in nonconjugated cells (same curve as in panel B), the cSMAC (n  9), and the
pSMAC (n 13) of the late IS. (D and E) Bar histograms showing the immobile fractions (D) and half-recovery times (E) calculated from the fitted curves. (F)
Example pseudocolored images depicted as described above for panel A. (G) Mean-fitted fluorescence recovery curves  standard errors of the means for
nonconjugated cells (n 15), the cSMAC (n 11), and the pSMAC (n 12) of the early IS. (H)Mean-fitted fluorescence recovery in nonconjugated cells (curve
as in panel G), the cSMAC (n 10), and the pSMAC (n 10) of the late IS. (I and J) Bar histograms showing the immobile fractions (I) and half-recovery times
(J). ns, not significant.
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CD81 colocalization with ICAM-1 increased with the progres-
sion of IS cell-cell conjugation (Fig. 2B). We then assessed the
ICAM-1–CD81 molecular interaction by phasorFLIM-FRET.
Analysis of the ICAM-1–CD81 donor-acceptor pair in nonconju-
gated cells revealed a low percentage of pixels at high FRETeff (see
Fig. S2B in the supplemental material). A clear increase in this
percentage was observed in initial cognate contacts (Fig. 4B), de-
spite the lack of clear ICAM-1 redistribution to the contact area.
As conjugation progressed, the percentage of high-FRETeff pixels
increased, first at the early IS and then throughout the late IS
TABLE 1 Derived apparent diffusion coefficients for CD81-mCherry
and ICAM-1–mEGFP in nonconjugated T cells and in different areas
and phases of the IS
Phase and
area
Mean D (m2/s) SDa
CD81-mCherry ICAM-1–mEGFP
No IS 0.42 0.04 0.46 0.05
Early cSMAC 0.44 0.11 0.38 0.15
Early pSMAC 0.60 0.17 0.16 0.04
Late cSMAC 0.21 0.05 0.17 0.03
Late pSMAC 0.22 0.06 0.21 0.05
a D, derived apparent diffusion coefficient.
FIG 4 CD81 interaction with ICAM-1 and CD3 at the IS. J77 cells cotransfected with mEGFP-mCherry pairs were conjugated with Raji/SEE cells and analyzed
by phasorFLIM-FRET. Data were analyzed by one-way ANOVAwith Bonferroni’s post hocmultiple-comparison test. (A) Examples of FRET-FLIM detection of
the CD9-CD81 pair in early and late ISs (the asterisks mark the Raji B cell location). In each chart, the EGFP lifetime distribution is shown in the phasor plot,
where the green and red linesmark 0 and 50%FRETeff, respectively. The black circular cursor in the phasor plot selects the subset of pixels shown in the correlated
FLIM images by the red mask (right-hand image inside each chart). mEGFP fluorescence intensity is depicted in grayscale (left-hand image inside each chart).
The graph shows quantification of the percentage of high-FRETeff pixels for no IS (T cells alone) (n 7), nonspecific contact (n 4), initial cognate contact (n
7), the early IS (n 7), and the late IS (n 7). (B) Examples of FRET-FLIMdetection for the ICAM-1–CD81 pair in early and late ISs, analyzed as described above
for panel A. The graph shows quantification of the percentage of high-FRETeff pixels: no IS (n 8), initial cognate contact (n 12), the early IS (n 5), and the
late IS (n 12). (C) Examples of FRET-FLIM detection for the CD3-CD81 pair in early and late ISs, analyzed as described above for panel A. The graph shows
quantification of the percentage of high-FRETeff pixels: no IS (n 6), nonspecific T cell-B cell contact (n 4), the early IS (n 10), and the late IS (n 20).
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contact, indicating ICAM-1 and CD81 molecular interactions
during IS progression (Fig. 4B). This increase in the CD81–
ICAM-1 association correlates directly with the increase inCD81–
ICAM-1 colocalization during IS maturation (Fig. 2B).
Since CD81 colocalized with CD3 at the IS (Fig. 2A), we also
analyzed the possible interaction between these proteins. In non-
conjugated cells, the average FRETeff value was below the detec-
tion limit of the technique, suggesting negligible CD3-CD81 mo-
lecular interactions (see Fig. S2B in the supplemental material).
However, we detected a very low percentage of pixels at high
FRETeff, which remained unchanged in nonspecific contacts (Fig.
4C). In the early IS, the percentage of high-FRETeff CD3-CD81
pixels in the cSMAC was significantly increased, and the late IS
displayed the greatest extent of interaction (Fig. 4C), suggesting
that thesemolecules are in close proximity as they spread from the
cSMAC throughout the contact. Although CD81 and CD3
showed a high level of colocalization at all times (Fig. 2A), phasor-
FLIM-FRET analysis indicated that direct protein-protein inter-
actions increase with the progression of the IS cell-cell contact
(Fig. 4C).
Together, these results show that CD81-CD3, CD81–ICAM-1,
and CD81-CD9 molecular interactions are induced progressively
during IS maturation.
Role of CD81 in the organization of the mature IS.We stud-
ied the effect ofCD81 silencing on the dynamics of IS constituents.
J77/ICAM-1–mEGFP cells transfected with control or CD81
siRNA (siCD81) (Fig. 5A) were conjugated with Raji/SEE cells for
different times and plated onto PLL-coated coverslips for 15 min
(Fig. 5B). We used ICAM-1–mEGFP to categorize the IS as an
early IS (pSMAC enrichment) (Fig. 5B, right) or late IS (enrich-
ment throughout the contact) (bottom right). CD81 knockdown
decreased the proportion of early ISs while increasing the propor-
FIG 5 CD81 controls IS organization. (A) J77 cells were cotransfected with control siRNA or siCD81 and ICAM-1–mEGFP, stained for CD81, and analyzed by
flow cytometry. The negative control, in gray, represents cells stained only with secondary antibody. (B) J77/ICAM-1–mEGFP cells treated with control or CD81
siRNAwere conjugated with Raji/SEE cells, and the percentage of conjugates in the early or late IS (monitored by ICAM-1 distribution) was quantified. Data are
means standard errors of themeans of 100 contacts (n 3 independent experiments). Right panels are example pseudocolored images of the ICAM-1–mEGFP
distribution and merged bright-field and blue channels (Raji/SEE) (asterisks). (C) J77/shControl or J77/shCD81 cells were incubated with Raji/SEE cells for the
indicated times. Data represent the fold changes in CD3 surface expression levels with respect to levels in shControl cells in the presence of nonactivated Raji cells
(0 min) and are shown as means standard errors of the means (n 5 in triplicate). (D) J77/shRNA T cells were conjugated with Raji/SEE B cells (SEE) (left),
or CH7/siRNA T cells were conjugated with Hom2/HA B cells (HA peptide) (right) for 20 min, and CD3 relocalization to the IS was measured. Data are means
standard errors of the means of 50 (SEE) and 100 (HA) conjugates (n 2 independent experiments each).
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tion of late synapses (Fig. 5B), strongly indicating that CD81 reg-
ulates IS maturation and ICAM-1 reorganization at the contact.
Next, we assessed the role of CD81 in CD3 reorganization.
After 15 min of conjugation with Raji/SEE cells, CD81-silenced
cells displayed lower levels of endogenous surface CD3 than did
control cells (Fig. 5C). Moreover, this decrease was accompanied
by impaired CD3 relocalization to the IS with respect to the rest of
the cell membrane in 20-min conjugates (Fig. 5D, left). This de-
crease in CD3 relocalization upon CD81 silencing was confirmed
with antigen-specific conjugates formed between CD81-silenced
CH7C17 T cells and Hom2 B cells loaded with HA peptide and
labeled with CMAC cell tracker (Hom2/HA cells) (Fig. 5D, right).
The role of CD81 in CD3 dynamics was further analyzed by total
internal reflection fluorescence microscopy (TIRFM). J77/CD3-
mEGFP cells transfected with siControl or siCD81 (Fig. 6A, left)
were plated onto anti-CD3-coated coverslips, and CD3 micro-
cluster dynamics was investigated (Fig. 6A; see alsoVideo S1 in the
supplemental material). Although TCRmicroclusters are station-
ary due to the immobility of the stimulating ligand on the glass,
there is protein flux in and out the assembled clusters (48) (see
Video S1 in the supplemental material), and the cSMAC formed
correctly in many cells (Fig. 6A, right). Interestingly, CD3 micro-
clusters at CD81-silenced cell membranes disappeared from the
TIRFM depth detection range (	90 nm) more rapidly (Fig. 6B),
while their tracks displayed an equal average speed (Fig. 6C), in-
dicating cluster internalization rather than movement to other
membrane regions outside the imaging field. Therefore, we also
observed a time-dependent reduction in the number of micro-
clusters (Fig. 6D) and cSMAC areas (Fig. 6E) in CD81-silenced
cells. These experiments suggest that CD81-CD3 interactions are
required for efficient retention of the CD3 signaling complex in T
cell plasma membranes during cognate interactions.
CD81 controls theT cell activation threshold. IS organization
in the absence of CD81 was further investigated by using two
different CD81 shRNA sequences, obtaining similar phenotypes
(Fig. 7A and data not shown). Surface expression levels of differ-
ent molecules were not significantly altered by CD81 silencing in
nonconjugated T cells (Fig. 7B). CD81 downregulation reduced
the total number of SEE-dependent conjugates (Fig. 7C), without
differences in contact duration (data not shown). CD81-depleted
cells displayed impaired microtubule-organizing center (MTOC)
translocation to the IS, with increased distance to the APC surface
(Fig. 7D). Moreover, CD81 downregulation enhanced F-actin re-
localization to the IS (Fig. 7E), despite similar F-actin polymeriza-
tion rates in control and CD81-silenced cells (Fig. 7F).
In the context of T cell-APC cognate interactions, CD81 down-
modulation not only altered IS organization but, as a conse-
quence, also impaired signaling and T cell activation. Indeed,
CD81 silencing reduced the levels of CD3, ZAP-70, LAT, and
extracellular signal-regulated kinase (ERK) phosphorylation with
FIG 6 CD81 regulates CD3 dynamics at the IS. (A, left) Flow cytometry analysis of J77 cells cotransfected with control siRNA or siCD81 and CD3-mEGFP and
stained for CD81. The negative control, in gray, represents cells stained only with secondary antibody. J77/CD3-mEGFP cells treated with siControl or siCD81
were plated onto CD3-coated coverslips and analyzed by TIRFM. (Right) Example pseudocolor images of time-maximal projections of CD3-mEGFP micro-
clusters at the cellmembrane of siRNA-treated cells. (B to E)Graphs showing the duration of detection of eachCD3microcluster (B), the speedmean of the tracks
(C), and, at each time point, the number of microclusters (D) and the cSMAC area (E). Data are means standard errors of the means for 8 cells under each
condition (n 2 independent experiments).
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the time of conjugation (Fig. 8A). A reduction in the level of CD3
downstream intracellular signaling during IS maturation was ob-
served with conjugates formed between CD81-silenced J77 T cells
and Raji/SEE B cells as well as with antigen-specific conjugates
formed between CD81-silenced CH7C17 T cells andHom2/HA B
cells (Fig. 8A). CD81-silenced T cells also showed lower mem-
brane expression levels of the T cell activation marker CD69 (Fig.
8B) and reduced IL-2 secretion (Fig. 8C) in both J77/Raji and
CH7/Hom2 conjugation systems.
In order to directly assess the role of CD81-mediated signaling
inT cell activation,CH7C17T cells were treatedwith fluorescently
labeled cell-permeable peptides corresponding to the C-terminal
sequence of CD81 or with a scrambled combination of the same 8
amino acids as a control. Treated T cells were then conjugated
withHom2/HA cells, and T cell activationwasmeasured by quan-
tifying CD69 expression levels (Fig. 8D). Treatment of T cells with
peptides containing the C-terminal sequence of CD81 did not
affect T cell activation, suggesting that CD81 direct downstream
signaling is not involved in T cell activation. Tetraspanin associa-
tions with several membrane proteins occur through their LEL
extracellular domain (49), and GST proteins fused to the LEL
extracellular domain (GST-LEL) of different tetraspanin mole-
cules have been used to perturb functions regulated by tetraspanin
microdomains, since they decrease the diffusion of tetraspanin
molecules at the plasma membrane (19). Pretreatment of
CH7C17 T cells with GST-LEL-CD81 before conjugation with
Hom2/HA B cells induced an increase in the CD69 expression
level in comparison with control GST alone (Fig. 8E), further in-
dicating that CD81 regulates T cell activation by interacting with
other membrane proteins through its extracellular domain rather
than by its direct intracellular signaling.
Taken together, these results suggest that CD81 is important for
the organizationofCD3at the IS and forCD3-mediated intracellular
signaling, regulating proper T cell signaling and activation.
DISCUSSION
In this study, we provide evidence that CD81 controls IS forma-
tion and progression through its dynamic interaction with CD3
FIG 7 CD81 controls IS formation. (A) J77 cells were transduced with CD81 shRNA or an empty vector (shControl), stained for CD81, and analyzed by flow
cytometry. The negative control represents cells stained onlywith secondary antibody. (B) Expression levels ofmembrane proteins determined by flow cytometry
inT cells depleted forCD81or not (shControl). Variationswere not statistically significant.Data are presented as fold changeswith respect to the expression levels
of each protein in control cells and are shown as means standard deviations from three independent experiments. (C) J77/shRNA cells were incubated with
Raji/SEE or Raji/SEE cells for 20 min, and the percentage of T cell-B cell contacts was quantified. Data are means  standard errors of the means for 100
contacts (n  3 independent experiments), determined by one-way ANOVA with Bonferroni’s post hoc multiple-comparison test. (D) J77/shRNA cells were
conjugated with Raji/SEE or Raji/SEE cells for 20 min and stained with antitubulin. Data are the MTOC distances from the IS (m) and are shown as
means  standard errors of the means for 100 conjugates (n  3 independent experiments), determined by one-way ANOVA with Bonferroni’s post hoc
multiple-comparison test. (E) J77/shRNA cells were conjugated with Raji/SEE cells for 20 min, and F-actin relocalization to the IS was measured. Data are
means standard errors of themeans for 50 conjugates (n 2 independent experiments). (F) J77/shRNAcells were stimulatedwith anti-CD3, fixed, labeledwith
phalloidin, and analyzed by flow cytometry. Data are the fold changes in F-actin content with respect to the expression level in the absence of the antibody (0min)
and are shown as means standard errors of the means (n 3 independent experiments performed in triplicate).
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and ICAM-1. A recent electron microscopy study of mouse ISs,
from contacts for up to 6 h, identified four distinct morphological
stages. Initial synapses (10 to 30 min) were characterized by con-
tacts through pseudopodia, while later phases corresponded to
specific distributions of intracellular structures at the IS area (50).
Previous descriptions of IS dynamics indicated that protein polar-
ization reaches a maximum by 	30 min (51), with increasing
interaction forces (52). T cells sustain the IS ring pattern for over
FIG 8 CD81 regulates the T cell activation threshold. (A) CD81-knocked-down J77 or CH7C17 T cells were conjugated for the indicated times with Raji/SEE
(SEE) and Hom2/HA (HA-peptide) B cells, respectively. Cells were then lysed and immunoblotted for phosphorylated and total CD3, ZAP-70, LAT, and
ERK1/2. Blots are from a representative experiment out of three; numbers below the blots indicate the phosphorylated/total signal ratio. (B and C) J77/shRNA
and Raji/SEE or CH7/shRNA and Hom2/HA cells were conjugated for 16 h. (B) Cells were labeled for CD69 and analyzed by flow cytometry. Data are the fold
changes in CD69 surface expression levels with respect to levels in shControl cells and are shown as means  standard errors of the means (n  4 [SEE] and
n 5 [HA] independent experiments). (C) Supernatantswere analyzed by an enzyme-linked immunosorbent assay.Data are the fold changes in levels of secreted
IL-2 with respect to those in shControl cells and are shown as means standard errors of the means (n 3 [SEE] and n 4 [HA] independent experiments).
(D) CH7 T cells preincubated with permeable CD81 or scrambled peptides were conjugated with Hom2/HA cells for 16 h. Data are the fold changes in CD69
surface expression levels with respect to those in control cells and are shown asmeans standard errors of themeans (n 2 independent experiments). (E) CH7
T cells preincubated with GST alone or GST-LEL-CD81 fusion proteins were conjugated withHom2/HA cells for 16 h. Data are the fold changes in CD69 surface
expression levels with respect to control cells and are shown as means standard errors of the means (n 2 independent experiments).
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1 h when plated onto lipid bilayers (53). In our analysis, we exam-
ined live T cell-B cell conjugates and discerned different IS steps
not detected in previous studies. IS stages were defined based on
protein redistribution, dynamics, and interactions at the contact
area during 1 h of conjugation, delineating three major IS stages:
initial cognate contacts, between polarized T cells and stimulated
APCs; the early IS, showing differential protein enrichment at the
cSMAC or pSMAC; and the late IS, with proteins evenly distrib-
uted throughout the IS and showing high protein-protein inter-
action levels (Fig. 9). Our data point to a regulation of the dynam-
ics of synapse architectural organization not only by size
differences in ectodomains of cell surface proteins (54) but also by
protein-protein interactions driven by TEMs.
This novel stepwise IS formation reveals an important role for
CD81. Our data indicate a correlation between colocalization and
protein-protein molecular interaction studies, with an increase in
the extent of CD81 associations as conjugation progressed, al-
though the full extent of interactions is underestimated in our
phasorFLIM-FRET experiments due to the competition with en-
dogenous untagged proteins. In early synapses, most CD81 is en-
gaged at the cSMAC, where it colocalizes and interacts directly
with CD3. In accordance, CD81 association with the CD3 sub-
unit was recently identified by a yeast two-hybrid screen (55).
Remarkably, at the same stage, ICAM-1,which is initially enriched
at the pSMAC, progressively redistributes throughout the contact,
with an increase in colocalization and a concomitant increase in
direct associations with CD81molecules. The high level of immo-
bility of CD81 and ICAM-1 molecules in this early stage indicates
that protein redistribution during IS progression could be regu-
lated by interactions with the cytoskeleton. In late synapses, CD81
redistributes evenly throughout the IS, showing similar dynamics
in the cSMAC and pSMAC, and colocalization and protein-pro-
tein interactions with CD3 and ICAM-1 are detected over a larger
area. In this IS stage, slow protein dynamics and high levels of
membrane protein-protein interactions suggest that IS protein
enrichment is regulated by interactions within TEMs. Cytoskele-
ton polarization toward cell-cell contacts is crucial for the forma-
tion of themature IS (56, 57). Accordingly, treatment of J77T cells
with the actin-depolymerizing toxin latrunculin A before incuba-
tion with Raji/SEE cells prevented IS formation, with the very few
T cell-B cell contacts observed being devoid of CD81-mCherry or
endogenous CD3 accumulation at the IS (data not shown), in
agreement with previous works (5, 58). Cholesterol is an essential
component of TEMs (46), with an important role in the IS context
(59–62). T cell-B cell conjugation as well as CD81 and CD3 accu-
mulation at the IS were also significantly reduced by the treatment
of J77 T cells with methyl--cyclo-dextrin, a drug that extracts
membrane cholesterol, before incubation with Raji/SEE cells
(data not shown). TEMsmight thenmodulate IS organization and
maturation by mediating the link between membrane proteins
and lipids, cytoskeleton components, and signaling molecules.
CD81 diffusion properties in nonconjugated T cells are similar
to those of ICAM-1, in agreement with previous studies showing
comparable apparent diffusion coefficients for ICAM-1 and tet-
raspanins CD9 and CD151 in nude endothelial cell plasma mem-
branes (19). We also observed similarities in ICAM-1 and CD81
diffusion properties in the late IS. The mobility of tetraspanins
CD63 and CD82 is comparable to the one of MHCII in late endo-
somal multivesicular bodies (63), and it is possible that their dif-
fusional behavior also varies according to IS sublocalization and
maturation stages. Although CD81 is also present in intracellular
vesicles and is secreted through exosomes (64), CD81 is expressed
mainly on the plasma membrane of T cells. To study CD81 and
ICAM-1 dynamics, we have chosen small bleaching areas (	8.5
m2) located specifically at the T cell plasma membrane.
CD81 regulates the correct timing of IS maturation. CD81
downregulation accelerates the proportion of late IS conjugates
(based on the ICAM-1 distribution pattern) and reduces CD3
relocalization to the IS, enhancing CD3 microcluster internaliza-
tion following TCR stimulation. TCR microcluster movement
(53) and signal termination (5) are controlled by the actin cyto-
skeleton. CD81 couldmediate functional interactions between ac-
tin and CD3 or ICAM-1. On the IS APC side, continuous ICAM-1
recycling is controlled by LFA-1, actin, and microtubules (65). In
B cells, CD81microdomains alongside the actin cytoskeleton play
a key role in regulating CD19 mobility and in organizing CD19
and B cell receptor (BCR) interactions that lead to BCR signaling
(66). CD81 is connected to the actin cytoskeleton through its as-
sociation with ezrin-radixin-moesin (ERM) proteins (67), which
are recruited to the IS and play a role in T cell activation (68).
F-actin dynamics is also regulated by Rho GTPases (69), and
CD81 was recently shown to associate directly with the small
GTPase Rac-1 (70, 71). However, our data for CD81 C-terminal
cell-permeable peptides and soluble GST-LEL-CD81 fusion pro-
teins suggest that the role of CD81 as an IS organizer might be
related to its ability to interact with other transmembrane pro-
teins, regulating their diffusional properties and subcellular local-
ization rather than direct signaling or anchoring to the cytoskele-
ton through its C-terminal domain. Moreover, the opposite
effects observed with CD81 silencing, which accelerates IS matu-
FIG9 Definition of IS stages based on protein redistribution (CD81, ICAM-1,
and CD3) at the T cell-APC contact area during 1 h of conjugation: initial
cognate contacts, characterized by membrane contacts between polarized T
cells and stimulated APCs; the early IS, showing differential protein enrich-
ment at the cSMAC(CD3 andCD81) or the pSMAC(ICAM-1); and the late IS,
with even protein distribution throughout the IS contact area.
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ration, and GST-LEL-CD81, which slows down diffusion of TEM
proteins, indicate that CD81 microdomains regulate the time of
permanence of TCR signaling at the IS plasma membrane, mod-
ulating the TCR signaling threshold.
Thus, as an IS organizer, CD81 regulates T cell activation.
CD81-silenced T cells display reduced MTOC translocation to-
ward the IS, which is TCR dependent (72) and necessary for full T
cell activation (73) but independent of actin polarization (74).
CD81 silencing reduces TCR downstream signaling, decreasing
CD3, ZAP-70, LAT, and ERK1/2 phosphorylation, in agreement
with data showing that CD81 T cell costimulation activates TCR
and ERK more strongly than does CD28 (75). Also, CD81-
knocked-down T cells have reduced IL-2 secretion, which is de-
pendent on ERK1/2 activation (76), and express lower levels of the
T cell activation marker CD69. This observed decrease in T cell
activation in CD81-silenced human T cells may seem contradic-
tory with previous data showing hyperproliferative responses of
CD81/mouse T cells to CD3 cross-linking (55, 77). However, it
is important to note that there are fundamental differences in the
CD81 expression patterns between the two species. Opposite to
human T cells, CD81 is expressed inmouse T cells only after T cell
activation (37, 78). Recently, noncanonical T cell stimulationwith
antibodies against CD4 and the TCR showed a slight increase in
CD69 expression levels in CD81-silenced T cells (55). This differ-
ence from our results is probably related to different T cell activa-
tion protocols. In our work, we have stimulated CD81-silenced T
cells through antigen presentation by APCs by using two different
conjugation systems (Raji/SEE and Hom2/HA cells), obtaining
similar results with both.Moreover, in agreementwith our results,
CD81/ T cells do not develop Th2 responses when activated by
antigen-presenting B cells, with reduced IL-4 production (79),
andCD81 acts as a T cell-costimulatorymolecule in humanT cells
(37, 38, 75).
TEMs accommodate numerous molecules, allowing the regu-
lation of receptor avidity. Our findings provide evidence that
CD81 regulates IS molecular organization by associating with
CD3 and ICAM-1, controlling their segregation in the cSMAC
and pSMACover the course of ISmaturation. The role of CD81 as
a microdomain organizer is thus important for synapse matura-
tion timing and necessary for a correct T cell signaling threshold
that leads to full T cell activation.
ACKNOWLEDGMENTS
This workwas supported by SAF2011-25834 from the SpanishMinistry of
Science and Innovation, INDISNET-S2011/BMD-2332 from the Comu-
nidad deMadrid, Cardiovascular Network RD12-0042-0056 from the In-
stituto Salud Carlos III, and ERC-2011-AdG 294340-GENTRIS.
We declare that we have no competing financial interests.
We thank S. Bartlett for English editing, M. Vicente-Manzanares for
critical reading, and Soraya López-Martín for technical support. Micros-
copywas performed at theCNICMicroscopy andDynamic ImagingUnit.
REFERENCES
1. Yokosuka T, Saito T. 2010. The immunological synapse, TCRmicroclus-
ters, and T cell activation. Curr. Top. Microbiol. Immunol. 340:81–107.
2. Dustin ML, Olszowy MW, Holdorf AD, Li J, Bromley S, Desai N,
Widder P, Rosenberger F, van der Merwe PA, Allen PM, Shaw AS. 1998.
A novel adaptor protein orchestrates receptor patterning and cytoskeletal
polarity in T-cell contacts. Cell 94:667–677.
3. Monks CR, Freiberg BA, Kupfer H, Sciaky N, Kupfer A. 1998. Three-
dimensional segregation of supramolecular activation clusters in T cells.
Nature 395:82–86.
4. Lillemeier BF, Mortelmaier MA, Forstner MB, Huppa JB, Groves JT,
Davis MM. 2010. TCR and Lat are expressed on separate protein islands
on T cell membranes and concatenate during activation. Nat. Immunol.
11:90–96.
5. Varma R, Campi G, Yokosuka T, Saito T, Dustin ML. 2006. T cell
receptor-proximal signals are sustained in peripheral microclusters and
terminated in the central supramolecular activation cluster. Immunity
25:117–127.
6. Vardhana S, Choudhuri K, Varma R, Dustin ML. 2010. Essential role of
ubiquitin and TSG101 protein in formation and function of the central
supramolecular activation cluster. Immunity 32:531–540.
7. Yokosuka T, Kobayashi W, Sakata-Sogawa K, Takamatsu M,
Hashimoto-Tane A, Dustin ML, Tokunaga M, Saito T. 2008. Spatio-
temporal regulation of T cell costimulation by TCR-CD28 microclusters
and protein kinase C theta translocation. Immunity 29:589–601.
8. Hsu CJ, Hsieh WT, Waldman A, Clarke F, Huseby ES, Burkhardt JK,
Baumgart T. 2012. Ligand mobility modulates immunological synapse
formation and T cell activation. PLoS One 7:e32398. doi:10.1371/journal
.pone.0032398.
9. Fooksman DR, Vardhana S, Vasiliver-Shamis G, Liese J, Blair DA,
Waite J, Sacristan C, Victora GD, Zanin-Zhorov A, Dustin ML. 2010.
Functional anatomy of T cell activation and synapse formation. Annu.
Rev. Immunol. 28:79–105.
10. Mittelbrunn M, Yanez-Mo M, Sancho D, Ursa A, Sanchez-Madrid F.
2002. Cutting edge: dynamic redistribution of tetraspanin CD81 at the
central zone of the immune synapse in both T lymphocytes and APC. J.
Immunol. 169:6691–6695.
11. Delaguillaumie A, Lagaudriere-Gesbert C, Popoff MR, Conjeaud H.
2002. Rho GTPases link cytoskeletal rearrangements and activation pro-
cesses induced via the tetraspanin CD82 in T lymphocytes. J. Cell Sci.
115:433–443.
12. Engering A, Pieters J. 2001. Association of distinct tetraspanins with
MHC class IImolecules at different subcellular locations in human imma-
ture dendritic cells. Int. Immunol. 13:127–134.
13. Imai T, Kakizaki M, Nishimura M, Yoshie O. 1995. Molecular analyses
of the association of CD4 with two members of the transmembrane 4
superfamily, CD81 and CD82. J. Immunol. 155:1229–1239.
14. Kropshofer H, Spindeldreher S, Rohn TA, Platania N, Grygar C, Daniel
N, Wolpl A, Langen H, Horejsi V, Vogt AB. 2002. Tetraspan microdo-
mains distinct from lipid rafts enrich select peptide-MHC class II com-
plexes. Nat. Immunol. 3:61–68.
15. Shibagaki N, Hanada K, Yamashita H, Shimada S, Hamada H. 1999.
Overexpression of CD82 on human T cells enhances LFA-1/ICAM-1-
mediated cell-cell adhesion: functional association between CD82 and
LFA-1 in T cell activation. Eur. J. Immunol. 29:4081–4091.
16. Hemler ME. 2005. Tetraspanin functions and associated microdomains.
Nat. Rev. Mol. Cell Biol. 6:801–811.
17. Yanez-Mo M, Barreiro O, Gordon-Alonso M, Sala-Valdes M, Sanchez-
Madrid F. 2009. Tetraspanin-enriched microdomains: a functional unit
in cell plasma membranes. Trends Cell Biol. 19:434–446.
18. Boucheix C, Rubinstein E. 2001 Tetraspanins. Cell. Mol. Life Sci. 58:
1189–1205.
19. Barreiro O, Zamai M, Yanez-Mo M, Tejera E, Lopez-Romero P, Monk
PN, Gratton E, Caiolfa VR, Sanchez-Madrid F. 2008. Endothelial adhe-
sion receptors are recruited to adherent leukocytes by inclusion in pre-
formed tetraspanin nanoplatforms. J. Cell Biol. 183:527–542.
20. Espenel C, Margeat E, Dosset P, Arduise C, Le Grimellec C, Royer CA,
Boucheix C, Rubinstein E, Milhiet PE. 2008. Single-molecule analysis of
CD9 dynamics and partitioning reveals multiple modes of interaction in
the tetraspanin web. J. Cell Biol. 182:765–776.
21. Levy S, Shoham T. 2005. The tetraspanin web modulates immune-
signalling complexes. Nat. Rev. Immunol. 5:136–148.
22. Sanyal M, Fernandez R, Levy S. 2009. Enhanced B cell activation in the
absence of CD81. Int. Immunol. 21:1225–1237.
23. Imai T, Yoshie O. 1993. C33 antigen and M38 antigen recognized by
monoclonal antibodies inhibitory to syncytium formation by human T
cell leukemia virus type 1 are both members of the transmembrane 4
superfamily and associate with each other andwith CD4 or CD8 in T cells.
J. Immunol. 151:6470–6481.
24. Mannion BA, Berditchevski F, Kraeft SK, Chen LB, Hemler ME. 1996.
Transmembrane-4 superfamily proteins CD81 (TAPA-1), CD82, CD63,
and CD53 specifically associated with integrin alpha 4 beta 1 (CD49d/
CD29). J. Immunol. 157:2039–2047.
Rocha-Perugini et al.
3656 mcb.asm.org Molecular and Cellular Biology
25. Barreiro O, Yanez-Mo M, Sala-Valdes M, Gutierrez-Lopez MD, Ovalle
S, Higginbottom A, Monk PN, Cabanas C, Sanchez-Madrid F. 2005.
Endothelial tetraspanin microdomains regulate leukocyte firm adhesion
during extravasation. Blood 105:2852–2861.
26. Bullard DC, Hu X, Schoeb TR, Collins RG, Beaudet AL, Barnum SR.
2007. Intercellular adhesion molecule-1 expression is required on multi-
ple cell types for the development of experimental autoimmune enceph-
alomyelitis. J. Immunol. 178:851–857.
27. Kim HR, Na BR, Kwon MS, Ko YS, Han WC, Jun CD. 2013. Dynamic
motile T cells highly respond to the T cell stimulation via PI3K-Akt and
NF-kappaB pathways. PLoS One 8:e59793. doi:10.1371/journal.pone
.0059793.
28. Roy J, Audette M, Tremblay MJ. 2001. Intercellular adhesion molecule-1
(ICAM-1) gene expression in human T cells is regulated by phosphotyrosyl
phosphatase activity. Involvement ofNF-kappaB, Ets, andpalindromic inter-
feron-gamma-responsive element-binding sites. J. Biol. Chem. 276:14553–
14561.
29. Kurzinger K, Reynolds T, Germain RN, Davignon D, Martz E, Springer
TA. 1981. A novel lymphocyte function-associated antigen (LFA-1): cel-
lular distribution, quantitative expression, and structure. J. Immunol.
127:596–602.
30. Segura E, Guerin C, Hogg N, Amigorena S, Thery C. 2007. CD8
dendritic cells use LFA-1 to capture MHC-peptide complexes from exo-
somes in vivo. J. Immunol. 179:1489–1496.
31. Balkow S, Heinz S, Schmidbauer P, Kolanus W, Holzmann B, Grabbe
S, Laschinger M. 2010. LFA-1 activity state on dendritic cells regulates
contact duration with T cells and promotes T-cell priming. Blood 116:
1885–1894.
32. Campanero MR, del Pozo MA, Arroyo AG, Sanchez-Mateos P, Her-
nandez-Caselles T, Craig A, Pulido R, Sanchez-Madrid F. 1993. ICAM-3
interacts with LFA-1 and regulates the LFA-1/ICAM-1 cell adhesion path-
way. J. Cell Biol. 123:1007–1016.
33. de la Fuente H, Mittelbrunn M, Sanchez-Martin L, Vicente-Manzanares
M, Lamana A, Pardi R, Cabanas C, Sanchez-Madrid F. 2005. Synaptic
clusters ofMHC class IImolecules induced onDCs by adhesionmolecule-
mediated initial T-cell scanning. Mol. Biol. Cell 16:3314–3322.
34. James JR, Vale RD. 2012. Biophysical mechanism of T-cell receptor
triggering in a reconstituted system. Nature 487:64–69.
35. Rodriguez-Plata MT, Puigdomenech I, Izquierdo-Useros N, Puertas
MC, Carrillo J, Erkizia I, Clotet B, Blanco J, Martinez-Picado J. 2013.
The infectious synapse formed betweenmature dendritic cells and CD4
T cells is independent of the presence of the HIV-1 envelope glycoprotein.
Retrovirology 10:42. doi:10.1186/1742-4690-10-42.
36. Tohma S, Hirohata S, Lipsky PE. 1991. The role of CD11a/CD18-CD54
interactions in human T cell-dependent B cell activation. J. Immunol.
146:492–499.
37. Todd SC, Lipps SG, Crisa L, Salomon DR, Tsoukas CD. 1996. CD81
expressed on human thymocytes mediates integrin activation and inter-
leukin 2-dependent proliferation. J. Exp. Med. 184:2055–2060.
38. VanCompernolle SE, Levy S, Todd SC. 2001. Anti-CD81 activates LFA-1
on T cells and promotes T cell-B cell collaboration. Eur. J. Immunol.
31:823–831.
39. Martinez-Martin N, Fernandez-Arenas E, Cemerski S, Delgado P,
Turner M, Heuser J, Irvine DJ, Huang B, Bustelo XR, Shaw A, Alarcon
B. 2011. T cell receptor internalization from the immunological synapse is
mediated byTC21 andRhoGGTPase-dependent phagocytosis. Immunity
35:208–222.
40. Montoya MC, Sancho D, Bonello G, Collette Y, Langlet C, He HT,
Aparicio P, Alcover A, Olive D, Sanchez-Madrid F. 2002. Role of
ICAM-3 in the initial interaction of T lymphocytes and APCs. Nat.
Immunol. 3:159–168.
41. Gordon-Alonso M, Sala-Valdes M, Rocha-Perugini V, Perez-
Hernandez D, Lopez-Martin S, Ursa A, Alvarez S, Kolesnikova TV,
Vazquez J, Sanchez-Madrid F, Yanez-Mo M. 2012. EWI-2 association
with alpha-actinin regulates T cell immune synapses and HIV viral infec-
tion. J. Immunol. 189:689–700.
42. Calabia-Linares C, Robles-Valero J, de la Fuente H, Perez-Martinez M,
Martin-Cofreces N, Alfonso-Perez M, Gutierrez-Vazquez C, Mittelb-
runn M, Ibiza S, Urbano-Olmos FR, Aguado-Ballano C, Sanchez-
Sorzano CO, Sanchez-Madrid F, Veiga E. 2011. Endosomal clathrin
drives actin accumulation at the immunological synapse. J. Cell Sci. 124:
820–830.
43. Caiolfa VR, Zamai M, Malengo G, Andolfo A, Madsen CD, Sutin J,
Digman MA, Gratton E, Blasi F, Sidenius N. 2007. Monomer dimer
dynamics and distribution of GPI-anchored uPAR are determined by cell
surface protein assemblies. J. Cell Biol. 179:1067–1082.
44. Digman MA, Caiolfa VR, Zamai M, Gratton E. 2008. The phasor
approach to fluorescence lifetime imaging analysis. Biophys. J. 94:L14–
L16. doi:10.1529/biophysj.107.120154.
45. Zacharias DA, Violin JD, Newton AC, Tsien RY. 2002. Partitioning of
lipid-modified monomeric GFPs into membrane microdomains of live
cells. Science 296:913–916.
46. Charrin S, Manie S, Thiele C, Billard M, Gerlier D, Boucheix C,
Rubinstein E. 2003. A physical and functional link between cholesterol
and tetraspanins. Eur. J. Immunol. 33:2479–2489.
47. Kovalenko OV, Yang X, Kolesnikova TV, Hemler ME. 2004. Evidence
for specific tetraspanin homodimers: inhibition of palmitoylation makes
cysteine residues available for cross-linking. Biochem. J. 377:407–417.
48. Douglass AD, Vale RD. 2005. Single-molecule microscopy reveals plasma
membrane microdomains created by protein-protein networks that ex-
clude or trap signaling molecules in T cells. Cell 121:937–950.
49. Stipp CS, Kolesnikova TV, Hemler ME. 2003. Functional domains in
tetraspanin proteins. Trends Biochem. Sci. 28:106–112.
50. Ueda H, Morphew MK, McIntosh JR, Davis MM. 2011. CD4 T-cell
synapses involve multiple distinct stages. Proc. Natl. Acad. Sci. U. S. A.
108:17099–17104.
51. Grakoui A, Bromley SK, Sumen C, Davis MM, Shaw AS, Allen PM,
DustinML. 1999. The immunological synapse: a molecular machine con-
trolling T cell activation. Science 285:221–227.
52. Hosseini BH, Louban I, Djandji D, Wabnitz GH, Deeg J, Bulbuc N,
Samstag Y, Gunzer M, Spatz JP, Hammerling GJ. 2009. Immune syn-
apse formation determines interaction forces between T cells and antigen-
presenting cells measured by atomic force microscopy. Proc. Natl. Acad.
Sci. U. S. A. 106:17852–17857.
53. Kaizuka Y, Douglass AD, Varma R, Dustin ML, Vale RD. 2007. Mech-
anisms for segregating T cell receptor and adhesion molecules during
immunological synapse formation in Jurkat T cells. Proc. Natl. Acad. Sci.
U. S. A. 104:20296–20301.
54. Burroughs NJ, Kohler K, Miloserdov V, Dustin ML, van der Merwe PA,
Davis DM. 2011. Boltzmann energy-based image analysis demonstrates
that extracellular domain size differences explain protein segregation at
immune synapses. PLoS Comput. Biol. 7:e1002076. doi:10.1371/journal
.pcbi.1002076.
55. Cevik SI, Keskin N, Belkaya S, Ozlu MI, Deniz E, Tazebay UH, Erman
B. 2012. CD81 interacts with the T cell receptor to suppress signaling.
PLoS One 7:e50396. doi:10.1371/journal.pone.0050396.
56. Beemiller P, Krummel MF. 2010. Mediation of T-cell activation by actin
meshworks. Cold Spring Harb. Perspect. Biol. 2:a002444. doi:10.1101
/cshperspect.a002444.
57. Billadeau DD, Nolz JC, Gomez TS. 2007. Regulation of T-cell activation
by the cytoskeleton. Nat. Rev. Immunol. 7:131–143.
58. Campi G, Varma R, Dustin ML. 2005. Actin and agonist MHC-peptide
complex-dependent T cell receptor microclusters as scaffolds for signal-
ing. J. Exp. Med. 202:1031–1036.
59. Chichili GR, Westmuckett AD, Rodgers W. 2010. T cell signal regulation
by the actin cytoskeleton. J. Biol. Chem. 285:14737–14746.
60. Gagnon E, Schubert DA, Gordo S, Chu HH, Wucherpfennig KW. 2012.
Local changes in lipid environment of TCR microclusters regulate mem-
brane binding by the CD3epsilon cytoplasmic domain. J. Exp. Med. 209:
2423–2439.
61. Gombos I, Kiss E, Detre C, Laszlo G, Matko J. 2006. Cholesterol and
sphingolipids as lipid organizers of the immune cells’ plasma membrane:
their impact on the functions of MHCmolecules, effector T-lymphocytes
and T-cell death. Immunol. Lett. 104:59–69.
62. Van Komen JS, Mishra S, Byrum J, Chichili GR, Yaciuk JC, Farris AD,
Rodgers W. 2007. Early and dynamic polarization of T cell membrane
rafts and constituents prior to TCR stop signals. J. Immunol. 179:6845–
6855.
63. Hoorn T, Paul P, Janssen L, Janssen H, Neefjes J. 2012. Dynamics within
tetraspanin pairs affect MHC class II expression. J. Cell Sci. 125:328–339.
64. Mittelbrunn M, Gutierrez-Vazquez C, Villarroya-Beltri C, Gonzalez S,
Sanchez-Cabo F, Gonzalez MA, Bernad A, Sanchez-Madrid F. 2011. Uni-
directional transfer of microRNA-loaded exosomes from T cells to antigen-
presenting cells. Nat. Commun. 2:282. doi:10.1038/ncomms1285.
65. Jo JH, Kwon MS, Choi HO, Oh HM, Kim HJ, Jun CD. 2010. Recycling
CD81 Organizes Immune Synapse Architecture
September 2013 Volume 33 Number 18 mcb.asm.org 3657
and LFA-1-dependent trafficking of ICAM-1 to the immunological
synapse. J. Cell. Biochem. 111:1125–1137.
66. Mattila PK, Feest C, Depoil D, Treanor B, Montaner B, Otipoby KL,
Carter R, Justement LB, Bruckbauer A, Batista FD. 2013. The actin and
tetraspanin networks organize receptor nanoclusters to regulate B cell
receptor-mediated signaling. Immunity 38:461–474.
67. Sala-Valdes M, Ursa A, Charrin S, Rubinstein E, Hemler ME, Sanchez-
Madrid F, Yanez-MoM. 2006. EWI-2 and EWI-F link the tetraspaninweb to
the actin cytoskeleton through their direct association with ezrin-radixin-
moesin proteins. J. Biol. Chem. 281:19665–19675.
68. Charrin S, Alcover A. 2006. Role of ERM (ezrin-radixin-moesin) pro-
teins in T lymphocyte polarization, immune synapse formation and in T
cell receptor-mediated signaling. Front. Biosci. 11:1987–1997.
69. Vicente-Manzanares M, Sanchez-Madrid F. 2004. Role of the cytoskele-
ton during leukocyte responses. Nat. Rev. Immunol. 4:110–122.
70. Quast T, Eppler F, Semmling V, Schild C, Homsi Y, Levy S, Lang T,
Kurts C, Kolanus W. 2011. CD81 is essential for the formation of mem-
brane protrusions and regulates Rac1-activation in adhesion-dependent
immune cell migration. Blood 118:1818–1827.
71. Tejera E, Rocha-Perugini V, Lopez-Martin S, Perez-Hernandez D,
Bachir AI, Horwitz AR, Vazquez J, Sanchez-Madrid F, Yanez-Mo M.
2013. CD81 regulates cell migration through its association with Rac
GTPase. Mol. Biol. Cell 24:261–273.
72. Lowin-Kropf B, Shapiro VS, Weiss A. 1998. Cytoskeletal polarization of
T cells is regulated by an immunoreceptor tyrosine-based activation mo-
tif-dependent mechanism. J. Cell Biol. 140:861–871.
73. Martin-Cofreces NB, Robles-Valero J, Cabrero JR, Mittelbrunn M,
Gordon-Alonso M, Sung CH, Alarcon B, Vazquez J, Sanchez-Madrid F.
2008. MTOC translocation modulates IS formation and controls sus-
tained T cell signaling. J. Cell Biol. 182:951–962.
74. Sedwick CE, Morgan MM, Jusino L, Cannon JL, Miller J, Burkhardt
JK. 1999. TCR, LFA-1, and CD28 play unique and complementary
roles in signaling T cell cytoskeletal reorganization. J. Immunol. 162:
1367–1375.
75. Sagi Y, Landrigan A, Levy R, Levy S. 2012. Complementary costimula-
tion of human T-cell subpopulations by cluster of differentiation 28
(CD28) and CD81. Proc. Natl. Acad. Sci. U. S. A. 109:1613–1618.
76. Genot E, Cleverley S, Henning S, Cantrell D. 1996. Multiple p21ras
effector pathways regulate nuclear factor of activated T cells. EMBO J.
15:3923–3933.
77. Miyazaki T, Muller U, Campbell KS. 1997. Normal development but
differentially altered proliferative responses of lymphocytes in mice lack-
ing CD81. EMBO J. 16:4217–4225.
78. Maecker HT, Todd SC, Kim EC, Levy S. 2000. Differential expression of
murine CD81 highlighted by new anti-mouse CD81monoclonal antibod-
ies. Hybridoma 19:15–22.
79. Deng J, Dekruyff RH, Freeman GJ, Umetsu DT, Levy S. 2002. Critical
role of CD81 in cognate T-B cell interactions leading toTh2 responses. Int.
Immunol. 14:513–523.
Rocha-Perugini et al.
3658 mcb.asm.org Molecular and Cellular Biology
